AUSTRALIA: Australia’s Biomanufacturing Sector Accelerates New Development
The biomanufacturing sector sees big wins down under.
The biomanufacturing sector sees big wins down under.
Siemens Mobility completes expansion in Germany; Novo Nordisk returns to Tianjin for new lab investment; Firmus Technology prepares for world's first AI Factory Zone in Australia.
EDGNEX ramps up an AI data center campus in Jakarta. Oracle opens a seven-story R&D center in Casablanca; Australia’s Element 25 expands manganese production in Pilbara that will supply a future plant in Louisiana.
NEXTDC plans billion-dollar digital campus in Australia; Chemicals manufacturer expands production capacity in Japan; Foxconn sets sights on a new facility in Houston.
Co-investment aids logistics needs at Australia's Port Botany; Canada-based biomanufacturer returns to Alberta; SAIL plans to double production capacity in India.
A port expansion in the Republic of the Congo; bioproducts in Queensland, Australia; more chips in Japan; India’s solar boost; and record robotics stats.
Thanks to an $850 million partnership between the Australian government and Norway-based Kongsberg Defence, a new long-range missile manufacturing facility is coming to the Newcastle Airport precinct by 2027.
Clean energy goals require the sometimes less-than-clean manufacture of the products charged with achieving those goals, from solar cells and panels to wind turbine blades and nacelles to all the EV- and semiconductor-related products that require critical minerals.
A State of High Performance
About 80% of Australia’s plant and animal life exists nowhere else on earth. And many are deadly.
I've lost Friday. It was there when I left home on Thursday.
CSL Behring continues to expand its four-site global network.
Is Australia about to deliver an about-face in renewable energy policy?
My father once mused that Australia and New Zealand exist so the rest of the world has something to envy.
The 140-turbine Macarthur Wind Farm site near Hamilton, 290 kilometers (180 miles) west of Melbourne, in the Shire of Moyne in the southeastern Australian state of Victoria, sits not far from several state and national parks, and just a long stone's throw inland from the coast at Port Fairy.
Melbourne is home to the largest cluster of life science companies in Australia, with 263 firms calling Victoria home. Over one-third of all companies listed on the Australian Securities Exchange’s Life Sciences and Biotech Index are in Melbourne, and more than 40 percent of the annual National Health and Medical Research Council funding budget, the equivalent of the National Institutes for Health, comes to Melbourne research organizations.
Even if they are not permanent jobs, 6,500 direct and indirect jobs will boost any area’s economic prospects. Chevron Australia’s Wheatstone Project, a major LNG plant investment on Australia’s northwest coast, will have that effect and will result in revenues to the government of about AU$20 billion (US$19 billion) and $17 billion (US$16 billion) to Australian businesses over the next 30 years.
With a seemingly endless string of disasters plaguing the world in the last year, most notably the massive earthquake and resulting tsunami in Japan, images of the devastating floods that swept across much of Queensland, Australia, have faded from memory for most not directly affected.
Research and Development: Supercomputer’s First Task Is Vision-Testing Simulation
BioMedical R D